Phase III KEYNOTE-590 study of chemotherapy plus pembrolizumab versus chemotherapy plus placebo as first-line therapy for patients (Pts) with advanced esophageal or esophagogastric junction (E/EGJ) cancer
| dc.contributor.author | Bhagia, P. | |
| dc.contributor.author | Zhu, Y. | |
| dc.contributor.author | Shah, S. | |
| dc.contributor.author | Doi, T. | |
| dc.contributor.author | Ozguroglu, M. | |
| dc.contributor.author | Kato, K. | |
| dc.contributor.author | Shah, M. A. | |
| dc.contributor.author | Enzinger, P. C. | |
| dc.contributor.author | Bennouna, J. | |
| dc.contributor.author | Shen, L. | |
| dc.contributor.author | Adenis, A. | |
| dc.contributor.author | Sun, J-M. | |
| dc.contributor.author | Cho, B. C. | |
| dc.contributor.author | Kojima, T. | |
| dc.contributor.author | Kostorov, V. | |
| dc.contributor.author | Hierro, C. | |
| dc.date.accessioned | 2021-03-05T18:44:07Z | |
| dc.date.available | 2021-03-05T18:44:07Z | |
| dc.identifier.citation | Kato K., Shah M. A. , Enzinger P. C. , Bennouna J., Shen L., Adenis A., Sun J., Cho B. C. , Ozguroglu M., Kojima T., et al., "Phase III KEYNOTE-590 study of chemotherapy plus pembrolizumab versus chemotherapy plus placebo as first-line therapy for patients (Pts) with advanced esophageal or esophagogastric junction (E/EGJ) cancer", 43rd ESMO Congress (ESMO), Munich, Almanya, 19 - 23 Ekim 2018, cilt.29 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_cbcb726a-1ace-4557-873a-cd57b1ef0ff5 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/134966 | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Onkoloji | |
| dc.subject | ONKOLOJİ | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.title | Phase III KEYNOTE-590 study of chemotherapy plus pembrolizumab versus chemotherapy plus placebo as first-line therapy for patients (Pts) with advanced esophageal or esophagogastric junction (E/EGJ) cancer | |
| dc.type | Bildiri | |
| dc.contributor.department | National Cancer Center - Japan , , | |
| dc.identifier.volume | 29 | |
| dc.contributor.firstauthorID | 155052 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Bildiri [64839]